Jin Yang Pharmaceutical Co. Ltd (007370) - Total Liabilities

Latest as of March 2026: ₩111.51 Billion KRW ≈ $75.57 Million USD

Based on the latest financial reports, Jin Yang Pharmaceutical Co. Ltd (007370) has total liabilities worth ₩111.51 Billion KRW (≈ $75.57 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Jin Yang Pharmaceutical Co. Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how Jin Yang Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See Jin Yang Pharmaceutical Co. Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Jin Yang Pharmaceutical Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Jin Yang Pharmaceutical Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Medicamen Biotech Limited NSE:MEDICAMEQ	India	Rs916.99 Million
EP Manufacturing Bhd KLSE:7773	Malaysia	RM361.86 Million
Union Corporation KO:000910	Korea	₩212.48 Billion
Ocean Group JSC VN:OGC	Vietnam	₫2.55 Trillion
Korea Ind KO:002140	Korea	₩143.90 Billion
Chumpower Machinery Corp TWO:4575	Taiwan	NT$1.30 Billion
iCRAFT Co. Ltd KQ:052460	Korea	₩44.90 Billion
Workhorse Group Inc NASDAQ:WKHS	USA	$74.85 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Jin Yang Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 007370 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.52	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.70	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.41	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jin Yang Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jin Yang Pharmaceutical Co. Ltd (2014–2025)

The table below shows the annual total liabilities of Jin Yang Pharmaceutical Co. Ltd from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩107.95 Billion ≈ $73.16 Million	+0.24%
2024-12-31	₩107.70 Billion ≈ $72.98 Million	+255.16%
2023-12-31	₩30.32 Billion ≈ $20.55 Million	-17.75%
2022-12-31	₩36.87 Billion ≈ $24.99 Million	+11.10%
2021-12-31	₩33.18 Billion ≈ $22.49 Million	+52.46%
2020-12-31	₩21.77 Billion ≈ $14.75 Million	-11.56%
2019-12-31	₩24.61 Billion ≈ $16.68 Million	-12.14%
2018-12-31	₩28.01 Billion ≈ $18.98 Million	-10.98%
2017-12-31	₩31.47 Billion ≈ $21.32 Million	+13.85%
2016-12-31	₩27.64 Billion ≈ $18.73 Million	-0.31%
2015-12-31	₩27.72 Billion ≈ $18.79 Million	+82.37%
2014-12-31	₩15.20 Billion ≈ $10.30 Million	--

About Jin Yang Pharmaceutical Co. Ltd

KQ:007370 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$33.03 Million

₩48.74 Billion KRW

Market Cap Rank

#23479 Global

#1576 in Korea

Share Price

₩3945.00

Change (1 day)

-3.78%

52-Week Range

₩3870.00 - ₩6740.00

All Time High

₩9262.22